Hutch News

Hutch News

Stories tagged 'Transplant and Immunotherapy'

Tinkering with T cells

How researchers are tweaking engineered immune cells’ cancer-targeting receptors — and why it matters

May 15, 2018 | By Susan Keown / Fred Hutch News Service

These immune cells are the cornerstone of emerging cancer therapies. And their unimaginably tiny, cancer-targeting molecular weapons — their receptors — are the focus of intense scientific tinkering.

View story >


Mariners honor cancer survivor Colin Craig

Seattle native works to support lifesaving research — like the immunotherapy that put his cancer in remission

May 3, 2018 | By Sabrina Richards / Fred Hutch News Service

Throughout the 2018 Major League Baseball season, Fred Hutch and the Seattle Mariners are recognizing “Hutch Heroes,” including lymphoma survivor Colin Craig, who works to support our lifesaving research.

View story >


Dr. Reema Jain developing methods to isolate, manipulate blood stem cells for T-cell therapy

Funding from Immunotherapy Integrated Research Center supports postdoc’s work

May 1, 2018 | By Susan Keown / Fred Hutch News Service

Dr. Reema Jain has received salary and research support from the Fred Hutch Immunotherapy Integrated Research Center.

View story >


‘Article of the Year’ nod to demo of machine learning for personalized medicine

Computer-generated algorithms could guide prevention, treatment of transplant complication, researchers showed

April 17, 2018 | By Susan Keown / Fred Hutch News Service

In its April issue, the American Journal of Epidemiology recognized a paper by Fred Hutchinson Cancer Research Center faculty member Dr. Elizabeth Krakow as one of its 10 best articles published in 2017.

View story >


Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal

T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers

April 16, 2018 | By Rachel Tompa / Fred Hutch News Service

In an effort to improve the efficacy of immunotherapy for solid tumors, Fred Hutch researchers have engineered a new type of protein that can rewire a 'kill switch' to stimulate T cells' activity instead.

View story >


How does leukemia escape from immunotherapy?

New tech enables deep dive into mysterious results, sets stage for future improvements

April 16, 2018 | By Susan Keown / Fred Hutch News Service

“We don’t stop asking what we can do better”: Fred Hutch researchers delve into failures to learn how to improve an experimental cancer immunotherapy.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.